[文献资料]参 考 文 献

Miles D . Management of toxicity in patients receiving therapy with bevacizumab .Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced ， unresectable non-small-cell lung cancer treated with carboplatin and paclitaxel plus bevacizumab .Tracheoesophageal （ TE ） fistula development in a phase Ⅱ trial of concurrent chemoradiation （ CRT ） and bevacizumab （ B ） in limited-stage small-cell lung cancer （ LS-SCLC ） . J Clin Oncol ， 2008 ， 26 （ s ） ： 7554a .